Virax Biolabs Group Ltd (VRAX) Free cash flow 2024–2025
Virax Biolabs Group Ltd (VRAX) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$5.2MFY2025 · since FY2024: -$7.2M → -$5.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$5.2M | +28.2% |
| FY2024 | -$7.2M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice